Evidence map›Paper›PMID 42490550›Full record

ArticleJournal of medical Internet research2026

Initial-Visit Specialty Triage in Rare Diseases Using Large Language Models: Retrospective Benchmarking Study.

Jie Song, Zhichuan Xu, Meng Xiao, Cheng Bi, Yuxin Zhang, Xin Zheng, Xiaoran Li, Qiongfang Cao, Ziyu Lu, Hao Yang and 1 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jie Song *Department of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0009-0007-1606-0605
Zhichuan Xu *Department of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0009-0002-2690-2961
Meng XiaoDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0009-0003-2860-4738
Cheng BiDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0000-0002-8076-2704
Yuxin ZhangDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0009-0000-3067-6341
Xin ZhengDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0009-0000-9300-8949
Xiaoran LiDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0009-0009-1370-9266
Qiongfang CaoDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0009-0007-9320-3112
Ziyu LuDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0009-0000-4764-0601
Hao YangDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0000-0002-3505-9403
Bairong ShenDepartment of Ophthalmology and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, No.2222, Xinchuan Road, Gaoxin District, Chengdu, Sichuan, 610041, China, 86 15995854635.ORCID http://orcid.org/0000-0003-2899-1531

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Specialty triage at first contact is an overlooked step in early diagnostic pathways for rare diseases. Patients often present with overlapping, multisystem, and atypical manifestations, making first-visit specialty selection challenging and potentially prolonging diagnostic pathways. Objective: The aim of this study is to evaluate the accuracy, response time, and consistency of large language models (LLMs) for initial-visit specialty triage in rare diseases across multiple datasets, and to compare their performance with registered nurses and nonmedical participants. Methods: In this retrospective benchmarking study, we used 5 rare disease datasets: a publication-derived case set, 3 RareBench-derived datasets, and a Facial phenotype-Gene-Disease Dataset-derived set. Fourteen LLMs were evaluated over 5 independent runs per case. Performance was assessed using accuracy, response time, and consistency, with subgroup analyses by model accessibility, reasoning mode, parameter scale, and phenotype count. Human comparison was conducted on the publication-derived case set using registered nurses and nonmedical participants. Results: Across datasets, model accuracy ranged from 0.4378 to 0.7141. Claude-opus-4-5 achieved the highest accuracy (0.7141) and consistency (0.9653), averaging 10.79 seconds per case. GPT-5.1 had the shortest response time (3.39 s/case) and high accuracy (0.6948). Proprietary models had numerically higher average accuracy than open-weight models (0.6973 vs 0.6365). Nonthinking models achieved higher average accuracy than thinking models (0.6789 vs 0.5826) and had shorter response times, although this exploratory comparison was based on a small number of thinking models. Accuracy varied by phenotype count, with higher performance in cases with 1 to 2 or more than 14 phenotypes. On the publication-derived case set, LLMs achieved higher average accuracy than registered nurses and nonmedical participants (0.5978 vs 0.4914 and 0.4573). Conclusions: LLMs showed potential as assistive tools for initial-visit specialty triage in rare diseases. Model choice, reasoning mode, and phenotype information density influenced performance, but subgroup findings should be interpreted cautiously. Future work should evaluate LLM-based specialty triage in prospective clinical settings and develop clinician-supervised workflows with traceable evidence support.

Indexed as

BenchmarkingRare DiseasesTriageHumansLarge Language ModelsRetrospective Studiesartificial intelligencedigital healthlarge language modelsrare diseasesspecialty triage

Identifiers

PMID42490550
PMCPMC13394855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.